Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1Breast Diseases 1

Interventions

Surveys and Questionnaires 18Blood Specimen Collection 16Specimen Handling 12Observation 6Magnetic Resonance Spectroscopy 6Surgical Procedures, Operative 5Radiotherapy 5trastuzumab deruxtecan 4ribociclib 4darolutamide 4Standard of Care 4Patient Reported Outcome Measures 4Letrozole 4Data Collection 4Cryosurgery 4Breath Tests 4Tomography, X-Ray Computed 3Radiation 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Biopsy 3Anastrozole 3lorlatinib 2cemiplimab 2atezolizumab 2Ultrasonography 2Trastuzumab 2Staining and Labeling 2Restraint, Physical 2Positron-Emission Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Body Height × 30 days × Clear all
NCT05006196 2026-05-20

IMOGEN

Perspectum

Active not recruiting
1,030 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡